Julia MacPherson

“twas agreed that [the deceased] usually had a comprehensive understanding of her mental health and medications and was an informal patient consenting to her care and treatment. Quetapine had been stopped due to concerns about seizures. A trial of Clozapine was commenced on 18 January 2016, prescribed off licence and [the deceased] and her family raised concerns with her clinicians who had made adjustments to her dose but she continued to experience side effects that she found difficult to tolerate. She had a home”